Filing Details
- Accession Number:
- 0000014272-23-000154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-07 17:24:35
- Reporting Period:
- 2023-08-03
- Accepted Time:
- 2023-08-07 17:24:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1773367 | M Robert Plenge | Bristol-Myers Squibb Company Route 206 And Province Line Road Princeton NJ 08543 | Evp, Chief Research Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2023-08-03 | 732 | $61.14 | 6,584 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 200 | Indirect | Family Trust |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.142 to $61.145, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Shares held in a family trust, where reporting person is a beneficiary.